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ABSTRACT 
 
In situ hybridization with 3DNA™ dendrimers is a novel tool for detecting low levels of mRNA in tissue sections and whole embryos. 
Fluorescently labeled dendrimers were used to identify cells that express mRNA for the skeletal muscle transcription factor MyoD in 
the early chick embryo. A small population of MyoD mRNA positive cells was found in the epiblast prior to the initiation of 
gastrulation, two days earlier than previously detected using enzymatic or radiolabeled probes for mRNA. When isolated from the 
epiblast and placed in culture, the MyoD mRNA positive cells were able to differentiate into skeletal muscle cells. These results 
demonstrate that DNA dendrimers are sensitive and precise tools for identifying low levels of mRNA in single cells and tissues. 
 
 
INTRODUCTION 
 
In situ hybridization is a powerful tool for analyzing gene 
expression. Although less quantitative than Reverse 
Transcriptase-Polymerase Chain Reaction (RT-PCR), in situ 
hybridization has the advantage of being able to localize 
messenger RNA (mRNA) to individual cells and to reveal 
qualitative differences in the level of gene expression within a 
heterogeneous tissue. However, in situ hybridization does have 
its limitations. A low level of gene expression in a small number 
of cells can go undetected. Such was the case in studies of the 
onset of expression of the MyoD family of skeletal muscle 
specific transcription factors. RT-PCR demonstrated the 
presence of MyoD mRNA in tissues of the chick embryo that 
give rise to the muscle forming somites (1), whereas in situ 
hybridizations using enzymatic or radiolableled oligonucleotide 
probes marked the onset of MyoD expression after somite 
formation (2-4). Clearly, a more sensitive probe was required to 
detect the low level of MyoD mRNA in tissue sections of the 
early embryo.  
 
Fluorescently labeled 3DNA™ dendrimers (Genisphere, Inc.) 
have proven to be sensitive and precise reagents for detecting 
mRNA in single cells in both tissue sections and early embryos 
(5). DNA dendrimers are branched, multilayered structures 
synthesized by sequential hybridizations of partially 
complementary DNA monomers (6-8). Antisense oligonucleotide 
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sequences are ligated to the ends of the outer arms via the use of 
T4 DNA ligase. Arms remaining single stranded are available for 
hybridization and cross-linking of complementary 
oligonucleotides previously conjugated with a choice of 
fluorochromes, 32P, digoxigenin, biotin or enzymes capable of 
generating signal producing reactions.  
 
The sensitivity and accuracy of fluorescent dendrimer probes 
were analyzed by mapping the expression of MyoD mRNA in 
the early chick embryo. MyoD mRNA was detected in the 
somites, the tissue that gives rise to nearly all the skeletal muscle 
in the body, as well as the presomitic mesoderm and epiblast of 
gastrulating and pregastrulating embryos (5). Additional 
confirmation of the validity of dendrimer labeling was carried out 
by sorting cells that express MyoD, and testing their potential to 
differentiate into skeletal muscle in vitro (9). 
 
MATERIALS AND METHODS 
 
3DNA™ dendrimers 
 
3DNA™ dendrimers labeled with the fluorochrome CyTM3 
were obtained from Genisphere, Inc. (Hatfield, PA). The 
following cDNA sequences for antisense mRNA were used: 
MyoD, 5’-TTC TCA AGA GCA AAT ACT CAC CAT TTG 
GTG ATT CCG TGT AGT AGC TGC TG 3’(10), chicken 
glyceraldehyde-3-dehydrogenase (GAPDH), 5’-ATC AAG TCC 
ACA ACA CGG TTG CTG TAT CCA AAC TCA TTG TCA 
TAC CAG GAA 3’ (11), and embryonic fast myosin, 5’-CAG 
GAG GTG CTG CAG GTC CTT CAC CGT CTG GTC CAG 
GTT CTT CTT CAT CCT CTC TCC AGG 3’ (12). Dendrimers 
lacking a specific recognition sequence were used as a negative 
control for background fluoresence.  
 
In situ hybridization 
 
The in situ hybridization procedure (5) was modified from that 
of Sassoon and Rosenthal (13) and Raap et al. (14). Briefly, White 
Leghorn chick embryos were staged according to the method of 
Hamburger and Hamilton (15). Embryos were fixed in 4% 
formaldehyde in phosphate buffered saline (PBS), embedded in 
paraffin, sectioned at 10µm, and applied to 0.2% gelatin coated, 
3-well Teflon printed slides (EMS). After paraffin removal, the 
tissue was permeabilized with Triton X-100 and pepsin, then 
incubated with dendrimers overnight at 37°C. Nuclei were 
labeled with bis-benzamide and the sections were mounted in 
Gelmount (Fisher). Sections were observed with a Nikon Eclipse 
800 epifluorescence microscope (Optical Apparatus), and images 
were captured with the Optronics DEI 750 video camera and the 
Image Pro Plus image analysis software program (Phase 3 
Imaging Systems).  
 
In situ hybridization also was performed on whole embryos. 
Embryos were rinsed in PBS and transferred to gelatin coated, 1-
well Teflon printed slides. The embryos were fixed, 
permeabilized, and labeled with dendrimers and bis-benzamide as 
described above.  
Magnetic cell sorting 
 
The epiblast was isolated from stages 3-5 embryos, dissociated in 
0.25% trypsin and EDTA (Invitrogen), centrifuged, and 
resuspended in Dulbecco’s Minimal Essential Medium (DMEM) 
containing 5% fetal bovine serum, 5% horse serum, 100 U of 
penicillin and streptomycin (Invitrogen), and 5% chick embryo 
extract (Myo medium). The G8 monoclonal antibody that 
specifically labels cells expressing MyoD (9, 16) was added at a 
concentration of 2µg/ml for 45 minutes at 37°C. After 
centrifugation, IgM microbeads tagged with iron (Miltenyi 
Biotech) were added to the cells. Cell sorting was carried out with 
the MiniMacs column separation unit (Miltenyi Biotech).  
 
Culturing of sorted cells 
 
MyoD positive/G8 positive cells were cultured under conditions 
that promote skeletal myogenesis (1, 17). Twenty thousand cells 
in 15 µl of Myo medium were plated on a tissue culture dish 
coated with gelatin and fibronectin. After 90 minutes, dishes were 
flooded with 1 ml of serum and hormone free DMEM/F12 
(Invitrogen). 
 
Immunofluorescence localization 
 
Cultures were fixed at 5 days with 2% formaldehyde, 
permeabilized with Triton X-100, and labeled with the skeletal 
muscle specific 12101 monoclonal antibody (18), followed by 
affinity purified goat anti-mouse Fab′-2 fragments conjugated 
with rhodamine (Jackson ImmunoResearch). Nuclei were stained 
with bis-benzamide. 
 
RESULTS 
 
Localization of MyoD mRNA in the somites and 
segmental plate mesoderm with fluorescent 
dendrimers 
 
The ability of DNA dendrimers to correctly localize MyoD 
mRNA was tested in sections through the somites of stage 14 
embryos. In situ hybridization with enzymatic and radiolabeled 
probes had demonstrated strong MyoD labeling in the dorsal 
medial lip of the dermomyotome (2-4, 19). Labeling with MyoD 
dendrimers also was abundant in the same region of the somite 
(Fig. 1A). A few cells in the sclerotome and the neural tube were 
labeled with dendrimers, a finding consistent with the fact that 
cells from the neural tube of the mouse embryo and spinal cord 
of the chick fetus differentiate into skeletal muscle in vitro (16, 
20). Dendrimers lacking a specific recognition sequence produced 
very little background, yielding only one to three randomly 
scattered dendrimers per section. By contrast, labeling with 
dendrimers to GAPDH was observed in all tissues (Fig. 1D). 
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Fig. 1: Localization of MyoD mRNA in the somite and segmental plate 
with fluorescent dendrimers. Sections through the stage 16 embryo were 
hybridized with Cy3 labeled dendrimers containing a recognition sequence for 
MyoD (A and E), GAPDH (D), embryonic fast myosin (G), or dendrimers 
lacking a specific recognition sequence (C). Photomicrographs are the merged 
images of Cy3 dendrimers (red) and bis-benzamide labeled nuclei (blue). 
Representative DIC images of A and E are shown in B and F. MyoD dendrimers 
were concentrated in the dermomyotome (dm) of the somite (A). A few 
dendrimers also were found in the sclerotome (sc) and neural tube (nt). GAPDH 
dendrimers labeled all tissues (D). Dendrimers lacking a specific recognition 
sequence did not bind to the somite or the segmental plate (sp) (C,H). MyoD 
mRNA was found in a small population of cells in the segmental plate (arrows) 
(E). Only a few dendrimers for myosin were found in the segmental plate (G). 
Bar, 9 µm. 
 
We next examined the expression of MyoD in the segmental 
plate mesoderm, the tissue that gives rise to the somites. 
Although conventional probes for in situ hybridization did not 
detect MyoD mRNA in the segmental plate, fluorescent 
dendrimers revealed the presence of a subpopulation of MyoD 
mRNA positive cells throughout the tissue (Fig. 1E). Only a few 
dendrimers to embryonic fast myosin, a marker for differentiated 
skeletal muscle cells (Fig. 1G), were found in the segmental plate. 
One to three dendrimers lacking a specific recognition sequence 
were found per section (Fig. 1C and H). 
 
Localization of MyoD mRNA in gastrulating and 
pregastrulating embryos 
 
RT-PCR demonstrated that MyoD was expressed in the embryo 
prior to the formation of the segmental plate mesoderm (1). In 
situ hybridizations were performed on paraffin sections through 
embryos in the early stages of gastrulation, as well as non-
embedded, whole embryos. In the gastrulating stage 4 embryo, 
MyoD mRNA was found in a small number of cells throughout 
the epiblast, mesoderm and endoderm (5) (Fig. 2A-D). The 
strongest staining was observed in the rostral end of the primitive 
streak near Hensen’s node (Fig. 2A).  
 
Fig. 2: Localization of MyoD mRNA in the stage 4 and stage 1 embryo 
with fluorescent dendrimers. In situ hybridizations with dendrimers to MyoD 
(A-E) and embryonic fast myosin (F) were performed on sections through the 
stage 4 embryo (A-D) and whole stage 1 embryos (E-F). Photomicrographs are 
the merged images of Cy3 dendrimers (red) and bis-benzamide labeled nuclei 
(blue). C and F contain insets of drawings of the stage 4 and stage 1 embryo, 
respectively. The letters indicate the area shown at high magnification in the 
photomicrographs. Strong labeling with MyoD dendrimers was seen in cells 
ingressing through the primitive streak (ps) at the level of Hensen’s node (A). 
MyoD mRNA was less abundant in the posterior portion of the primitive streak 
(B). In the lateral region of the embryo, MyoD was found in adjacent cells of the 
epiblast (Ep) and mesoderm (M) and in the mesoderm and endoderm (En) (C 
and D). MyoD mRNA was localized to a subpopulation of cells in the posterior 
epiblast of the stage 1 embryo (E). Myosin mRNA was not detected in the stage 1 
embryo (F). Bar, 9 µm. 
 
Directly after the egg is laid, the stage 1 embryo consists of only 2 
layers, the epiblast and hypoblast. Approximately 20 MyoD 
mRNA positive cells were identified in the posterior region of the 
epiblast (Fig. 2E). GAPDH dendrimers labeled most cells 
throughout the embryo. The lack of detection of GAPDH in 
every cell in paraffin sections could reflect an absence of 
ubiquitous expression at this stage of development or limited 
accessibility of dendrimers to mRNA in some cells. Only 1-3 
dendrimers to myosin (Fig. 2F) or those lacking a specific 
recognition sequence bound to the entire embryo. 
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Confirmation of myogenic potential of cells labeled 
with MyoD dendrimers 
 
To confirm that MyoD dendrimers were labeling cells with 
myogenic potential, MyoD mRNA positive cells were isolated 
from gastrulating embryos and placed in culture. To isolate the 
cells expressing MyoD mRNA, epiblasts were labeled with the 
G8 monoclonal antibody that recognizes a cell surface antigen 
present on the same cells that bind MyoD dendrimers (9, 16) 
(Fig. 3A). G8/MyoD positive and negative populations were 
separated by magnetic cell sorting (9). After 5 days in culture, 
cells were stained with monoclonal antibodies to sarcomeric 
myosin (21) and the skeletal muscle specific protein 12101 (18). 
In G8/MyoD positive cultures, 95% of the cells differentiated 
into skeletal muscle (Fig. 3B), where as only 4% of the 
G8/MyoD negative cells formed muscle (Fig. 3C) (9). These 
results demonstrate that dendrimers with a recognition sequence 
for MyoD mRNA accurately identify cells with myogenic 
potential. 
 
Fig. 3: Isolation and differentiation of cells that express MyoD mRNA in 
the stage 4 embryo. The stage 4 embryo was double labeled with MyoD 
dendrimers (red) and the G8 monoclonal antibody followed by a secondary 
antibody conjugated with Alexa 488 (green). Nuclei were labeled with bis-
benzamide (blue). Epiblast cells co-expressed the G8 antigen and MyoD mRNA 
(A). The G8 and MyoD positive and negative populations were isolated by 
magnetic cell sorting. On the fifth day in culture, cells were stained with the 
skeletal muscle specific antibody 12101 and a secondary antibody conjugated with 
rhodamine (red). Most G8 positive cells differentiated into skeletal muscle cells 
(B), whereas few cells in G8 negative cultures were labeled with the 12101 
antibody (C). Bar, 9 µm. 
 
DISCUSSION 
 
The sensitivity and resolution of the in situ hybridization 
procedure has been enhanced with the use of fluorescent 
dendrimers as probes for mRNA. Dendrimers revealed the 
presence of MyoD mRNA two days earlier than previously 
detected with enzymatic or radiolabeled probes (2-4, 18). Single 
cells containing a low level of MyoD mRNA were resolved due 
to the preciseness of the fluorescent signal and the minimal level 
of background from nonspecific binding.  
 
Messenger RNA can be detected at low levels in whole embryos 
at early stages of development and in tissue sections. Dendrimers 
also can be used to localize mRNA in cultured cells. The ability 
to label dendrimers with a variety of fluorochromes permits the 
localization of different mRNAs in the same tissue section. 
Dendrimers also can be tagged with 32P, biotin, and digoxigenin. 
Furthermore, in situ hybridizations with dendrimers can be 
combined with antibody labeling to localize mRNA and protein 
within the same cell. This capability led to the discovery of a cell 
surface antibody for cells expressing MyoD mRNA that was then 
used to isolate MyoD mRNA positive cells from the embryo and 
fetal organs (9, 16). The specificity of MyoD dendrimers for cells 
with myogenic potential was confirmed by demonstrating that the 
isolated population differentiated into skeletal muscle in culture 
(9, 16).  
 
The protocol for using dendrimers is straightforward, particularly 
for those experienced with conventional methods of in situ 
hybridization. The usual considerations of avoiding RNAase and 
DNAase contamination, selecting anti-sense oligonucleotide 
sequences that remain linear, and optimization of hybridization 
temperature also apply when using dendrimer probes. A unique 
feature of the dendrimer procedure is the use of pepsin instead of 
Proteinase K. The appropriate temperature and length of 
incubation with pepsin must be carefully determined. Exposure 
to pepsin for 10 minutes at room temperature results in adequate 
digestion of most tissues for dendrimer penetration and preserves 
morphology. However, dense tissues, such as liver, require a 12-
minute treatment with pepsin at room temperature, while the 
more fragile tissues of the early embryo are treated for only 5 
minutes at 4°C.  
 
Enzymatically labeled oligonucleotide probes that are smaller 
than dendrimers are particularly useful when performing whole 
mount in situ hybridization with older embryos and thicker 
tissues. While enzymatic probes are capable of amplifying the 
signal, resolution can be compromised due to the diffusion of the 
reaction product and accumulation of background. Neither 
dendrimers nor enzymatically labeled oligonucleotides are 
quantitative in tissue sections; however, relative comparisons of 
signal intensity can be made with both types of probes. Although 
the sensitivity of dendrimers needs to be determined, 
conceivably, a single mRNA could be detected with dendrimers 
due to the number of fluors present on each molecule.  
 
The most significant advantages of using fluorescent dendrimers 
for in situ hybridization are their low level of background from 
nonspecific binding and pinpoint emission from the fluorescent 
tag. A single labeled cell can be detected among thousands of 
non-expressing cells. Observing the “needle in the haystack” is 
not only critical for determining the onset of gene expression in a 
subpopulation of cells within the embryo, but for detecting stem 
cells in adult tissues and early metastasis of cancer cells. 
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PROTOCOLS 
 
Solutions 
 
Hybridization buffer 
 
30ml Deionized Formamide (Sigma) 
5ml 20X SSC Buffer (Sigma) 
345mg Sodium Phosphate (Sigma) 
2.5g Dextran Sulfate (Sigma) 
pH to 7.4 then add Nuclease Free Water (Ambion) to a final volume of 50ml 
Store at 4°C in the dark 
 
DNA stock solution 
 
10mg Sonicated Salmon Sperm (SSS) DNA (Sigma) in 1ml Nuclease Free Water 
Warm slightly or sonicate to get DNA into solution   
Store at -20°C 
Dilute 1:20 in Hybridization Buffer before use   
Final concentration when diluted is 0.5mg/ml 
 
RNA stock solution 
 
10mg Yeast RNA (Boehringer Mannheim) in 1ml Nuclease Free Water 
Warm slightly or sonicate to get RNA into solution   
Store at -20°C 
Dilute 1:20 in Hybridization Buffer before use   
Final concentration when diluted is 0.5mg/ml 
 
60% formamide in 2X SSC buffer 
 
60mls Deionized Formamide  
10mls 20X SSC 
30mls Nuclease Free Water 
Store at room temperature in the dark. 
 
Myo medium 
 
84mls DMEM (Invitrogen) 
5mls Fetal Bovine Serum (Invitrogen) 
5mls Horse Serum (Invitrogen) 
5mls Chick Embryo Extract (22) 
1ml Penicillin and Streptomycin 10,000 IU  (Cellgro) 
 
Equipment list 
 
1. 37°C Incubator  
2. 80°C Oven 
3. Microtome 
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Procedure for in situ hybridization with 3DNA™  dendrimers 
 
A. In situ hybridization with paraffin sections 
 
1. Sectioning paraffin embedded tissues 
 
a. All solutions are prepared with nuclease free water (Ambion). 
b. Tissue embedded in paraffin is sectioned at 10µm and placed in 3-well Teflon printed slides (Electron Microscopy Science) coated 
with 0.2% gelatin in nuclease free water. 
c. Place one section in each well. 
 
2. Deparaffinizing, hydrating, and dehydrating sections  
Xylene and ethanol rinses are carried out in glass staining dishes. 
 
All solutions are prepared with nuclease free water. 
 
a. Warm slides in a 80°C oven for 1 minute to melt the wax. This will help the tissue adhere to the slides. 
b. Place slides in xylene for 10 minutes.       
c. Place slides in fresh xylene for an additional 10 minutes. 
d. Rinse in 100% ethanol for 2 minutes. 
e. Hydrate tissue by placing slides in a graded series of ethanol: 90%, 80%, 70%, 50%, and 30%, 5 minutes in each solution. 
f. Rinse slides with 0.85% NaCl, 100µl per well, for 10 minutes. To remove solutions, tap base of slide on a paper towel. 
g. Rinse in 100µl PBS for 1 minute. 
h. Fix tissue with 100µl 4% formaldehyde in PBS for 20 minutes. 
i. Dehydrate tissue in 70%, 90% and 100% ethanols, 5 minutes in each solution. 
   
3. Prehybridization 
 
All solutions are prepared with nuclease free water. 
 
a. Treat slides with 100µl 0.1%Triton X-100 for 10 minutes. 
b. Rinse slides with 100µl PBS for 1 minute. 
c. Incubate with 0.1% Pepsin (Boehringer Manheim) in 0.01M HCl, 33µl per well, for 5 to 10 minutes at room temperature or 4°C, 
depending on the tissue. 
d. Rinse with 33µl PBS for 1 minute. 
e. Postfix with 33µl 1% formaldehyde in PBS for 10 minutes 
f. Dehydrate tissue in 70%, 90%, and 100% ethanols, 5 minutes in each solution. 
g. Air dry slides. 
 
4. Hybridization 
 
All solutions are prepared with nuclease free water 
 
a. Place yeast RNA into 80°C oven for 10 minutes. 
b. To 500µl of Hybridization buffer add: 
25µl of SSS DNA stock solution 
25µl of Yeast RNA stock solution 
c. Dilute dendrimers in hybridization buffer containing DNA and RNA to a final concentration of 3pg/µl. 
d. Add 33µl of dendrimer solution to each well. 
e. Cover with 22mm square, siliconized coverslips (Hampton Research), one per well. Do not use nonsiliconized coverslips.  
f. Place slides in a 100mm petri dish on filter paper soaked with 20X SSC buffer to create a humid chamber. 
g. Place dish in 80°C oven for 10 minutes. 
h. Place dish in a 37°C incubator and incubate overnight.  
i. Place slides in 100mm petri dish with 15mls PBS for 15 minutes to float coverslips off the well and then gently remove them from 
slides. 
j. Incubate slides in 60% formamide in 2X SSC buffer for 10 minutes. 
k. Counterstain with Bis-Benzamide, 1µg/ml deionized water, for 5 minutes. 
l. Place 1 drop of Gelmount medium (Fisher) on each slide well and apply one 22 x 50mm coverslip over all three wells.  
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m. After one hour, seal edges of coverslip with nail polish. Store in dark. For best results let slide sit overnight before viewing. View 
within one week of preparation. 
 
B. In situ hybridization with whole embryos 
 
All solutions are prepared with nuclease free water. 
 
1. Rinse embryo in PBS. 
2. Place embryo on a 1mm nucleopore filter (Costar). 
3. Transfer embryo to a 1 well Teflon printed slide coated with 0.2% gelatin. 
4. Fix embryo in 100µl 4% formaldehyde for 20 minutes. 
5. Dehydrate embryo in 100µl 70%, 90%, and 100% ethanols, 5 minutes in each solution.  
6. Follow the same procedure as above for the remainder of the protocol, beginning with the Triton X-100 step during 
prehybridization. Use 100µl of solution for each step. 
7. Remove the embryo from the nucleopore filter just prior to placing in 100% ethanol during the prehybridization step. Position the 
embryo in the center of the slide for air drying. DO NOT coverslip the embryo during the overnight hybridization step. 
